Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 542-547

  Haynes, William G ^a   Morgan, Donald A ^a   Djalali, Ali ^a   Sivitz, William I ^a   Mark, Allyn L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Autonomic nervous system; Brain; Leptin; Obesity; Renal nerves; Sympathetic nervous system

Indexed keywords

LEPTIN; MELANOCORTIN;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; APPETITE; ARTICLE; BROWN ADIPOSE TISSUE; HORMONAL REGULATION; KIDNEY BLOOD FLOW; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; THERMOGENESIS; VASOMOTOR REFLEX;

EID: 0032899719     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.542     Document Type: Article

References (35)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
2. Stephens TW, Basinski M, Bristow PK, Bue-Vallesky JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hslung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. The role of neuropeptide Y in the anti-obesity action of the obese gene product. Nature. 1995;377:530-532.
3. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by loss of neuropeptide Y. Science. 1996;274: 1704-1708.
4. Schwartz M, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest. 1996;98:1101-1106.
5. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131-141.
6. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 1997;385:165-168.
7. Egawa M, Yoshimatsu H, Bray GA. Preoptic area injection of corticotrophin-releasing hormone stimulates sympathetic activity. Am J Physiol. 1990;259:R799-R806.
8. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol. 1991;260:R329-R334.
9. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-278.
10. Chagnon YC, Chen WJ, Perusse L, Chagnon M, Nadeau A, Wilkison WO, Bouchard C. Linkage and association between the melanocortin receptors 4 and 5 genes and obesity related phenotypes in the Quebec Family Study. Mol Med. 1997;3:663-673.
11. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stem MP, MacCluer JW, Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet. 1997;15:273-276.
12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A. Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19:155-157.
13. 7] substituted MSH analogues for the melanocortin receptors. Peptides. 1997;18:1009-1013.
14. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO, Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature. 1994;371: 799-802.
15. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997;94: 8878-8883.
16. Boston BA, Blaydon KM. Varnerin J. Cone RD. Independent and additive effects of central POMC and leptin pathways on murine obesity Science. 1997;278:1641-1644.
17. Muntzel MS, Morgan DA, Mark AL, Johnson AK. Intracerebroventricular administration of insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol. 1994;267:R1350-R1355.
18. Morgan DA, Balon TW, Ginsberg BH, Mark AL. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol. 1993;264:R423-R427.
19. Low MJ, Simerly RB, Cone RD. Receptors for the melanocortin peptides in the central nervous system. Curr Opin Endocrinol Diabetes. 1994;1:79-88.
20. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-549.
21. Halaas JL, Gajiwalla KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543-546.
22. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540-543.
23. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature. 1996;380:677-682.
24. Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Phvsiol. 1998; 274:R248-R54.
25. Kask A, Rago L, Mutulis F, Pahkla R, Wikberg JES, Schiàth HB. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Commun. 1998; 245:90-93.
26. Feng JD, Dao T, Lipton JM. Effects of preoptic microinjections of alpha-MSH on fever and normal temperature control in rabbits. Brain Res. 1987;18:473-477.
27. Zemel MB, Moore JW, Moustaid N, Kim JH, Nichols JS, Blanchard SG, Parks DJ, Harris C, Lee FW, Grizzle M, James M, Wilkison WO. Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice. Int J Obes. 1998;22:678-683.
28. Cheung C, Thornton J, Kuijper J, Weigle D, Clifton D, Steiner R. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology. 1997;138:4489-4493.
29. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic proopiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 1997;46: 2119-2123.
30. Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 1997;138:5063-5066.
31. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects. Nature. 1997;390:349. Letter.
32. Satoh N, Ogawa Y, Katsura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by melanocortin system. Neurosci Lett. 1998;249:107-110.
33. Hart MN., Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980;2:419-423.
34. DiBona GF. Sympathetic nervous system influences on the kidney: role of hypertension. Am J Hypertens. 1989;2:119S-124S.
35. Morgan DA, Thorén P, Staudt SM, Mark AL. Differential effects of anesthesia on heart rate (HR), renal (RSNA), and lumbar sympathetic nerve activity (LSNA) in the rat. FASEB J. 1988;2:A1690. Abstract.